F.D.A. Seeks Investigation of Its Own Alzheimer’s Drug Approval
The Food and Drug Administration on Friday called for a federal investigation of the process that led to the approval of a new drug for Alzheimer’s disease that has spurred sharp criticism from lawmakers and the medical community. In a letter to the Department of Health and Human Services’ independent Office of the Inspector General,…